Oxygen treatment beneficial in diabetes-prone mice

Oxygen treatment beneficial in diabetes-Prone mice

(HealthDay) -- Hyperbaric oxygen treatment of a preclinical diabetes mouse model reduces the incidence of diabetes and preserves insulin-producing β-cells, according to a study published online May 7 in Diabetes.

Gaetano Faleo, Ph.D., from the University of Miami, and colleagues examined the effect of one hour of daily hyperbaric oxygen therapy with 100 percent oxygen on the development of autoimmune diabetes in nonobese diabetic mice.

The researchers found that the incidence of cyclophophamide-induced diabetes fell from 85.3 to 48 percent. The incidence of spontaneous diabetes dropped from 85 percent in controls to 65 percent in treated mice. In mice with prediabetes, treatment with hyperbaric oxygen was associated with reduced insulitis, reduced T-cell proliferation in vitro, elevated CD62L expression in T-lymphocytes, decreased costimulation markers (CD40, DC80, and CD86), and major histocompatibility complex class II expression in dendritic cells. However, hyperbaric oxygen was less effective once autoimmunity was established. Compared with controls, hyperbaric oxygen therapy reduced apoptosis and increased proliferation of + cells.

"Hyperbaric oxygen therapy reduces autoimmune incidence in nonobese diabetic mice via increased resting T-lymphocytes and reduced activation of dendritic cells with preservation of β-cell mass resulting from decreased apoptosis and increased proliferation," Faleo and colleagues conclude.

Several authors disclosed financial ties to Converge Biotech Inc., which partially funded the study.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Gene therapy reverses type 1 diabetes in mice

Jun 21, 2010

Researchers have developed an experimental cure for Type 1 diabetes, a disease that affects about one in every 400 to 600 children and adolescents. They will present their results in a mouse model of Type 1 diabetes on Sunday ...

Gene therapy reverses type 1 diabetes in mice

Jun 06, 2011

An experimental cure for Type 1 diabetes has a nearly 80 percent success rate in curing diabetic mice. The results, to be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston, offer possible hope of ...

Recommended for you

Study explores effects of metformin in obese children

Dec 18, 2014

(HealthDay)—For obese hyperinsulinemic children, metformin seems to decrease perceived hunger and increase perceived fullness, according to a study published online Dec. 8 in Diabetes, Obesity and Metabolism.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.